Nitric oxide induces phosphodiesterase 4B expression in rat pulmonary artery smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 4, 2006, Pages

  Busch, Cornelius J ^a,b   Liu, Heling ^a   Graveline, Amanda R ^a   Bloch, Kenneth D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adenosine 3 ,5 cyclic monophosphate; Cross talk; Guanosine 3 ,5 cyclic monophosphate; S nitroso L glutathione

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOVIRUS VECTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOHEXIMIDE; DACTINOMYCIN; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; ISOENZYME; KT 5823; MESSENGER RNA; MUTANT PROTEIN; N 6 (1 IMINOETHYL)LYSINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVB; ROLIPRAM; S NITROSO GLUTATHIONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; PHOSPHODIESTERASE INHIBITOR; S NITROSOGLUTATHIONE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; RNA TRANSLATION; SMOOTH MUSCLE FIBER; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME INDUCTION; GENE EXPRESSION; GUANYLATE CYCLASE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHODIESTERASE INHIBITORS; PULMONARY ARTERY; RATS; ROLIPRAM; S-NITROSOGLUTATHIONE; TRANSCRIPTION, GENETIC;

EID: 33646546995     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00298.2005     Document Type: Article

References (42)

1. Aizawa T, Wei H, Miano JM, Abe J, Berk BC, and Yan C. Role of phosphodiesterase 3 in NO/cGMP-mediated anti-inflammatory effects in vascular smooth muscle cells. Circ Res 93: 406-413, 2003.
2. Algara-Suarez P and Espinosa-Tanguma R. 8Br-cGMP mediates relaxation of tracheal smooth muscle through PKA. Biochem Biophys Res Commun 314: 597-601, 2004.
3. Beltman J, Becker DE, Butt E, Jensen GS, Rybalkin SD, Jastorff B, and Beavo JA. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains. Mol Pharmacol 47: 330-339, 1995.
4. Boerth NJ, Dey NB, Cornwell TL, and Lincoln TM. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34: 245-259, 1997.
5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
6. Browner NC, Sellak H, and Lincoln TM. Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells. Am J Physiol Cell Physiol 287: C88-C96, 2004.
7. Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, and Palmetshofer A. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem 275: 33536-33541, 2000.
8. Chiche JD, Schlutsmeyer SM, Bloch DB, de la Monte SM, Roberts JD Jr, Filippov G, Janssens SP, Rosenzweig A, and Bloch KD. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem 273: 34263-34271, 1998.
9. Ciani E, Guidi S, Bartesaghi R, and Contestabile A. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem 82: 1282-1289, 2002.
10. Cornwell TL, Arnold E, Boerth NJ, and Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol Cell Physiol 267: C1405-C1413, 1994.
11. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
12. D'Sa C, Tolbert LM, Conti M, and Duman RS. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons. J Neurochem 81: 745-757, 2002.
13. Farooqui SM, Al-Bagdadi F, Houslay MD, Bolger GB, Stout R, Specian RD, Cherry JA, Conti M, and O'Donnell JM. Surgically induced cryptorchidism-related degenerative changes in spermatogonia are associated with loss of cyclic adenosine monophosphate-dependent phosphodiesterases type 4 in abdominal testes of rats. Biol Reprod 64: 1583-1589, 2001.
14. Filippov G, Bloch DB, and Bloch KD. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942-948, 1997.
15. Francis SH and Corbin JD. Purification of cGMP-binding protein phosphodiesterase from rat lung. Methods Enzymol 159: 722-729, 1988.
16. Gonzalez GA and Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680, 1989.
17. Gu M, Lynch J, and Brecher P. Nitric oxide increases p21(Waf1/Cip1) expression by a cGMP-dependent pathway that includes activation of extracellular signal-regulated kinase and p70(S6k). J Biol Chem 275: 11389-11396, 2000.
18. Gustafsson AB and Brunton LL. Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1β and NO: role of cGMP-stimulated PDE2. Am J Physiol Cell Physiol 283: C463-C471, 2002.
19. Hagiwara M, Brindle P, Harootunian A, Armstrong R, Rivier J, Vale W, Tsien R, and Montminy MR. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol 13: 4852-4859, 1993.
20. Houslay MD and Adams DR. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370: 1-18, 2003.
21. Jurado S, Sanchez-Prieto J, and Torres M. Elements of the nitric oxide/cGMP pathway expressed in cerebellar granule cells: biochemical and functional characterisation. Neurochem Int 45: 833-843, 2004.
22. Klein C. Nitric oxide and the other cyclic nucleotide. Cell Signal 14: 493-498, 2002.
23. Li Z, Ajdic J, Eigenthaler M, and Du X. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 101: 4423-4429, 2003.
24. Maurice DH, Palmer D, Tilley DG, Dunkerley HA, Netherton SJ, Raymond DR, Elbatarny HS, and Jimmo SL. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 64: 533-546, 2003.
25. Mayr B and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609, 2001.
26. Murray F, MacLean MR, and Pyne NJ. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension. Br J Pharmacol 137: 1187-1194, 2002.
27. 2+ stores in smooth muscle. Am J Physiol Cell Physiol 274: C1199-C1205, 1998.
28. Murthy KS, Zhou H, and Makhlouf GM. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle. Am J Physiol Cell Physiol 282: C508-C517, 2002.
29. Netherton SJ and Maurice DH. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol Pharmacol 67: 263-272, 2005.
30. Pauvert O, Salvail D, Rousseau E, Lugnier C, Marthan R, and Savineau JP. Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery. Biochem Pharmacol 63: 1763-1772, 2002.
31. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, and Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17: 3045-3051, 1998.
32. Phillips PG, Long L, Wilkins MR, and Morrell NW. cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 288: L103-L115, 2005.
33. Pilz RB and Casteel DE. Regulation of gene expression by cyclic GMP. Circ Res 93: 1034-1046, 2003.
34. Polson JB and Strada SJ. Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Annu Rev Pharmacol Toxicol 36: 403-427, 1996.
35. Pyne NJ and Furman BL. Cyclic nucleotide phosphodiesterases in pancreatic islets. Diabetologia 46: 1179-1189, 2003.
36. Resta TC, O'Donaughy TL, Earley S, Chicoine LG, and Walker BR. Unaltered vasoconstrictor responsiveness after iNOS inhibition in lungs from chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 276: L122-L130, 1999.
37. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
38. Shepherd M, McSorley T, Olsen AE, Johnston LA, Thomson NC, Baillie GS, Houslay MD, and Bolger GB. Molecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoform. Biochem J 370: 429-438, 2003.
39. Soff GA, Cornwell TL, Cundiff DL, Gately S, and Lincoln TM. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100: 2580-2587, 1997.
40. Takata M, Filippov G, Liu H, Ichinose F, Janssens S, Bloch DB, and Bloch KD. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol 280: L272-L278, 2001.
41. Walford G and Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost 1: 2112-2118, 2003.
42. Wang P, Myers JG, Wu P, Cheewatrakoolpong B, Egan RW, and Billah MM. Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun 234: 320-324, 1997.